214 related articles for article (PubMed ID: 25870979)
21. [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].
Ozger H; Eralp L; Atalar AC; Toker B; Ayan I; Kebudi R; Bağbek S; Başaran M; Ağaoğlu F; Dizdar Y; Bilgiç B
Acta Orthop Traumatol Turc; 2007; 41(3):211-9. PubMed ID: 17876121
[TBL] [Abstract][Full Text] [Related]
22. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.
Harting MT; Lally KP; Andrassy RJ; Vaporciyan AA; Cox CS; Hayes-Jordan A; Blakely ML
J Cancer Res Clin Oncol; 2010 Apr; 136(4):561-70. PubMed ID: 19784847
[TBL] [Abstract][Full Text] [Related]
23. A study of 853 high grade osteosarcomas from a single institution-Are outcomes in Indian patients different?
Puri A; Byregowda S; Gulia A; Crasto S; Chinaswamy G
J Surg Oncol; 2018 Feb; 117(2):299-306. PubMed ID: 28833209
[TBL] [Abstract][Full Text] [Related]
24. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
[TBL] [Abstract][Full Text] [Related]
25. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Díaz R; Salom M; Baixauli F; Gómez J; Llavador M; Castel V
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of chemotherapy-induced necrosis in osteosarcoma patients receiving pasteurized autografts.
Joo MW; Kang YK; Yoo CY; Cha SH; Chung YG
PLoS One; 2017; 12(2):e0172155. PubMed ID: 28196121
[TBL] [Abstract][Full Text] [Related]
27. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute.
Staals EL; Bacchini P; Bertoni F
Cancer; 2008 Apr; 112(7):1592-9. PubMed ID: 18300258
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
[TBL] [Abstract][Full Text] [Related]
30. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis.
Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F
Tumori; 2018 Jun; 104(3):202-206. PubMed ID: 30086698
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.
Bispo Júnior RZ; Camargo OP
Clinics (Sao Paulo); 2009; 64(12):1177-86. PubMed ID: 20037705
[TBL] [Abstract][Full Text] [Related]
32. [Survival analysis of 104 cases of osteosarcoma with lung metastases].
Ren J; Xu YF; Kuang TH; Chen J; Liu YX
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):263-268. PubMed ID: 28550665
[No Abstract] [Full Text] [Related]
33. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Nataraj V; Batra A; Rastogi S; Khan SA; Sharma MC; Vishnubhatla S; Bakhshi S
J Surg Oncol; 2015 Nov; 112(6):662-8. PubMed ID: 26381138
[TBL] [Abstract][Full Text] [Related]
34. Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: A retrospective cohort study of 153 patients.
Cates JM; Schoenecker JG
Acta Oncol; 2016 Aug; 55(8):1036-9. PubMed ID: 27145235
[TBL] [Abstract][Full Text] [Related]
35. Patterns of care and outcomes of adult osteosarcoma in a tertiary care cancer centre in Pakistan.
Imtiaz S; Kazmi A
J Pak Med Assoc; 2014 Oct; 64(10):1166-70. PubMed ID: 25823158
[TBL] [Abstract][Full Text] [Related]
36. Post operative infection and increased survival in osteosarcoma patients: are they associated?
Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
[TBL] [Abstract][Full Text] [Related]
38. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
[TBL] [Abstract][Full Text] [Related]
39. Osteosarcoma in patients older than 65 years.
Longhi A; Errani C; Gonzales-Arabio D; Ferrari C; Mercuri M
J Clin Oncol; 2008 Nov; 26(33):5368-73. PubMed ID: 18809616
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients.
Durnali A; Alkis N; Cangur S; Yukruk FA; Inal A; Tokluoglu S; Seker MM; Bal O; Akman T; Inanc M; Isikdogan A; Demirci A; Helvaci K; Oksuzoglu B
Med Oncol; 2013; 30(3):624. PubMed ID: 23749307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
